Can AI chatbots replace doctor questionnaires for chronic pain patients?

NCT ID NCT07336537

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study is testing whether conversational AI software can effectively collect health information from people with chronic pain. Participants will chat with a digital tool that asks about their physical symptoms, emotions, and social life. The goal is to see if patients find this approach acceptable, easy to use, and practical for real-world settings.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Digital Biopsychosocial Conversational Data Collection Software (AI-powered chatbot)
What this could lead to
If successful, this could show that conversational AI is a practical way to gather detailed health information from chronic pain patients, potentially improving how their condition is understood and managed.
What could go wrong
This is a small, early-stage feasibility study (100 participants) with no control group. It only measures how acceptable and usable the software is, not whether it improves health outcomes. Technical glitches or patient discomfort with AI conversations could limit its usefulness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BEHAVIORAL HEALTH CHALLENGES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome mental disorder Psychological Well-Being

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AugMend Health at MIT.nano Immersion Lab

    RECRUITING

    Cambridge, Massachusetts, 02139, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.